TaperCommunityclonazepam
Boxed Warning
Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death. Risks of abuse, misuse, and addiction, which can lead to overdose and death. Physical dependence and life-threatening withdrawal reactions.
Clonazepam is a long-acting benzodiazepine approved for seizure disorders and panic disorder. It is widely used off-label for anxiety and insomnia. It has a high potency relative to other benzodiazepines (0.5mg clonazepam ≈ 10mg diazepam).
0.25mg, 0.5mg, 1mg, 2mg
Tablets: 0.5mg, 1mg, 2mg; Orally disintegrating tablets: 0.125mg, 0.25mg, 0.5mg, 1mg, 2mg
Category D (positive evidence of risk)
Positive allosteric modulator at GABA-A receptors, binding to the benzodiazepine site and enhancing the effect of GABA. This increases chloride ion conductance, resulting in neuronal hyperpolarization and CNS depression. Also has serotonergic activity that may contribute to its anti-panic effects.
Long-acting benzodiazepine. Ashton Manual is the gold-standard tapering resource. Tablets can be split and dissolved in water for micro-tapering.
Follow Ashton Manual protocols. Consider crossover to diazepam for smoother taper. Never stop abruptly — seizure risk.
Evidence-based phased reduction schedule. Always taper under medical supervision.
| Phase | Duration | Notes |
|---|---|---|
| Stabilization | 2-4 weeks | Establish consistent dosing schedule before beginning taper. Your prescriber will switch PRN to fixed-schedule dosing. |
| Initial reductions | 2-4 weeks per step | Small, gradual reductions determined by your prescriber. Hold at each dose until stable before proceeding. |
| Middle reductions | 3-6 months | Progressively smaller reductions. Your prescriber may recommend water titration for precision. |
| Final reductions | 3-6 months | The hardest phase. Some prescribers recommend crossing over to diazepam for a smoother taper. |
1-3 days after reduction (delayed by long half-life)
5-14 days
4-8 weeks for acute symptoms
Anxiety, insomnia, tinnitus, depersonalization, and sensory hypersensitivity can persist 6-18 months. Neurological recovery from long-term use can take 1-2 years.
Practical insights shared by members tapering Klonopin. Not medical advice — always consult your prescriber.
Toxicity
CNS depression, respiratory depression (especially combined with opioids/alcohol). Physical dependence develops with chronic use. Abrupt discontinuation can cause seizures, delirium tremens-like syndrome, and death.
Pharmacokinetics
Rapidly and completely absorbed after oral administration. Bioavailability ~90%. Tmax 1–4 hours. Food does not significantly affect absorption.
~3.2 L/kg
Hepatic via CYP3A4 to the inactive metabolite 7-aminoclonazepam (via nitroreduction) and other hydroxylated metabolites. Acetylation of 7-aminoclonazepam also occurs.
Renal (~50–70% as metabolites). Less than 2% excreted unchanged in urine.
~85%
~55 mL/min (total body clearance)
Browse our map of deprescribing-informed providers worldwide.